Prostate Cancer News and reporting on prostate cancer. Jul 13, 2022 Oncologists Seeing Lack of PARP Inhibitor Response in MSI-High, BRCA-Mutant Prostate Cancer Patients Jun 16, 2022 Ratio Therapeutics Launches to Develop More Target-Specific, Less Toxic Radiopharmaceuticals Premium Jun 10, 2022 Telix Pharmaceuticals, RefleXion Medical to Develop Illuccix-Guided Radiotherapy for Prostate Cancer Jun 7, 2022 African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show Jun 6, 2022 VISION Trial Sub-Studies Refine Pluvicto Benefit as Radiopharmaceutical Access Barriers Persist Premium Jun 6, 2022 Foundation Medicine, Arvinas Partner to Develop CDx For Prostate Cancer Drug Jun 2, 2022 Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership May 20, 2022 Prostate Cancer UK Funds Study of Angle's Parsortix Liquid Biopsy Test in Prostate Cancer May 20, 2022 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests May 16, 2022 Point Biopharma to Launch Phase I Study of FAP-Targeted Radiopharmaceutical in Canada May 13, 2022 NanoMab Conducting Study of Lantheus' PD-L1 Imaging Agent May 11, 2022 Guidelines Update Supports Use of Genomic Tests in Early Prostate Cancer Management May 5, 2022 Novartis Pauses US Pluvicto Production Due to Possible Quality Issues Apr 28, 2022 Janssen Seeking European Union Approval for Zejula in HRR-Positive Prostate Cancer Apr 26, 2022 Novartis Q1 Revenues Grow 1 Percent Amid Organizational Restructuring, Shifting Growth Drivers Apr 18, 2022 AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests Apr 12, 2022 Blue Earth Therapeutics to Begin Phase I/II Trial of Targeted Radiopharmaceutical for mCRPC Apr 11, 2022 Adding Genetic Information to PSA Improves Biomarker's Performance in Prostate Cancer Diagnosis Apr 11, 2022 UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine study Apr 11, 2022 Telix Acquires Exclusive Worldwide Rights to Eli Lilly's Olaratumab Load More Breaking News Sirnaomics Launches Phase I/II Trial of RNAi Therapeutic for Facial Skin Cancer Lesions Verismo Therapeutics Files IND to Study Cell Therapy in Advanced Mesothelin-Expressing Solid Tumors In Brief This Week: Genprex, Strata Oncology, Bristol Myers Squibb, Turning Point Therapeutics Innovative Cellular Therapies Begins Trial of Autologous CAR T-Cell Therapy in Colorectal Cancer Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit Sanofi Ends Development of Breast Cancer Drug Amcenestrant
